Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression

• Autorzy: Dudzik P. , Trojan S.E. , Ostrowska B. , Lasota M. , Dulinska-Litewka J. , Laidler P. , Kocemba-Pilarczyk K.A.
• Języki publikacji: EN

Abstrakty

EN

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2019
• Tom: 66
• Numer: 4
• Opis fizyczny: p.619-625,fig.,ref.

Twórcy

autor

Dudzik P.

• Chair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Trojan S.E.

• Chair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Ostrowska B.

• Chair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Lasota M.

• Department of Transplantation, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Dulinska-Litewka J.

• Chair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Laidler P.

• Chair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Kocemba-Pilarczyk K.A.

• Chair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

Identyfikatory

DOI

10.18388/abp.2019_ 2907